LifeMD, Inc. (LFMDP) — Analyst outlook / Analyst consensus target is. Based on 3 analyst ratings, the consensus is bullish — 3 Buy.
Analysts estimate Earnings Per Share (EPS) of $-0.55 and revenue of $0.21B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.53 vs est $-0.55 (beat +4.1%). 2025: actual $-0.23 vs est $-0.21 (missed -8.1%). Analyst accuracy: 94%.
LFMDP Analyst Ratings
Buy
Based on 3 analysts giving stock ratings to LifeMD, Inc. in the past 3 months
EPS Estimates — LFMDP
94%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.53
vs Est –$0.55
▲ 4.3% off
2025
Actual –$0.23
vs Est –$0.21
▼ 7.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — LFMDP
88%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.212B
vs Est $0.206B
▲ 3.2% off
2025
Actual $0.194B
vs Est $0.234B
▼ 20.6% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
